EMRAP and ITE Prep (Feb 2021)

ITE Prep: https://aliemu.com/courses/ite-question-sets-51-80/

EM:RAP for Asynchronous Learning! For credit, first, listen to the entire podcast. Your participation in the discussion board here is your attestation that you have listened and engaged with the content in a meaningful way.

https://www.emrap.org/episode/ema2021february/abstract1lumbar

When you have finished listening to the podcast, answer the following questions:

1. Please list three things you learned from this podcast that you were not aware of before.
2. Are there any areas of your practice that you would change after listening to this podcast? If so, what would you do differently?
3. What topic mentioned in this podcast is considered too “bleeding edge” (ex. too new, lacks enough evidence, not ready for prime time). Are there any practices mentioned in this podcast that you would consider to not be applicable to our practice setting here at BMC?

One comment

  1. 1.
    a. I was unaware of the low sensitivity of CXR for diagnosing pneumonia and will definitely consider alternative imaging/empiric treatment if I have a high suspicion
    b. I was unaware of how much more proximal DVTs can be during pregnancy and that up to 72% can be iliofemoral
    c. I was unaware of just how sensitive CTV is for diagnosing CVT and am reassured to know that it performs just about as well as MRI/MRV as it is must easier to get a CTV than those imaging modalities in the department
    2. In terms of intractable headaches especially with recurrent presentations, vision changes, other red flags I plan on including CVT on my differential more and considering imaging with CTV more often as it is a great imaging modality and a diagnosis that I do not want to miss.
    3. I think the YEARS algorithm is awesome and was glad to see it did so well in validation. I think that for PE risk stratification in the future this will become our go to strategy, but since it has not yet been adopted in our department I won’t start using it quite yet.

Post Your Comment